Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/01/1998US5843921 Therapeutic food composition and method to diminish blood sugar fluctuations
12/01/1998US5843919 Composition and method for the treatment of arthritis
12/01/1998US5843918 Anti-endotoxin compounds
12/01/1998US5843917 5-Fluorouracil derivatives
12/01/1998US5843916 Cyclic amp analogues, individually and in pairs, to inhibit neoplastic cell growth
12/01/1998US5843914 Neurturin and related growth factors
12/01/1998US5843911 Hyaluronidase inhibitor containing god-type ellagitannin as active ingredient
12/01/1998US5843910 Colchicine derivatives and the therapeutical use thereof
12/01/1998US5843908 Pradimicins l and fl, and derivatives thereof
12/01/1998US5843907 Pharmaceutical composition containing 2-O-α-d-glucopyranosyl-l-ascorbic acid
12/01/1998US5843906 Meta-substituted phenylene sulphonamide derivatives
12/01/1998US5843903 Targeted cytotoxic anthracycline analogs
12/01/1998US5843894 Methods for reduced renal uptake of antibody fragments
12/01/1998US5843890 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T
12/01/1998US5843738 Oligonucleotide modulation of cell adhesion
12/01/1998US5843735 Aklavinone C-11 hydroxylase, gene coding for same, expression vector therefor, and process for preparing hybrid antibiotics by using said vector
12/01/1998US5843714 DNA encoding a novel human proteolipid
12/01/1998US5843678 Osteoprotegerin binding proteins
12/01/1998US5843668 Human SQM1 protein homolog
12/01/1998US5843653 Method for detecting a target molecule in a sample using a nucleic acid ligand
12/01/1998US5843646 DNA molecules encoding murine son of sevenless (mSOS) gene and mSOS polypeptides
12/01/1998US5843641 Methods for the daignosis, of familial amyotrophic lateral sclerosis
12/01/1998US5843498 Method for depressing methanogenesis in the rumen of a ruminant
12/01/1998US5843497 Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
12/01/1998US5843482 Products and processes for the treatment of the alimentary canal
12/01/1998US5843481 Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
12/01/1998US5843480 Controlled release diamorphine formulation
12/01/1998US5843479 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
12/01/1998US5843478 Lanperisone formulation
12/01/1998US5843475 Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
12/01/1998US5843474 Method of dialysis treatment, and dialysis apparatus related thereto
12/01/1998US5843472 Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
12/01/1998US5843469 Lipid soluble forms of thiamine for prevention and treatment of age-related cognitive impairment of the nervous system
12/01/1998US5843465 Emulsion formulation
12/01/1998US5843458 Recombinant human cytomegalovirus having a US2 deletion
12/01/1998US5843449 Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
12/01/1998US5843441 Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma
12/01/1998US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843435 Immunotherapy of cancer with allogeneic lymphocytes
12/01/1998US5843432 Retroviral vectors for the treatment of tumors, and cell lines containing them
12/01/1998US5843413 Antiperspirants and method of applying antiperspirant using a shaped article
12/01/1998US5843411 Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
12/01/1998US5843408 Semi-paste oral preparations
12/01/1998US5842476 Method for controlling fertility
12/01/1998CA2060139C Triazole derivative
12/01/1998CA2054213C Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same
12/01/1998CA2042494C Photodynamic inactivation of viruses in cell-containing compositions
12/01/1998CA2026216C Optically active benzyl alcohol compound and the use thereof
12/01/1998CA2018573C Lyophilized preparation of 6-(3-dimethylaminopropionyl) forskolin
12/01/1998CA2016089C Salts of azelastine having improved solubility
12/01/1998CA2009593C Medicament containing dihydrolipoic acid as active substance
12/01/1998CA1340154C Substituted vinylcephalosporins, processes for their preparation and their use as medicaments
11/1998
11/30/1998CA2233577A1 Histidine kinase
11/30/1998CA2233554A1 Novel compounds
11/30/1998CA2233547A1 Histidine kinase
11/29/1998CA2233561A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/28/1998CA2238554A1 Aryloxyalkylamines with serotonin receptor activity
11/27/1998CA2232817A1 Novel compounds
11/26/1998WO1998053068A1 Smad7 and uses thereof
11/26/1998WO1998052966A1 Tissue specific prodrug
11/26/1998WO1998052965A1 20-ARALKYL-5α-PREGNANE DERIVATIVES
11/26/1998WO1998052959A1 Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
11/26/1998WO1998052958A1 Human uncoupling protein 3
11/26/1998WO1998052951A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998WO1998052949A1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections
11/26/1998WO1998052948A1 Compounds for inhibition of ceramide-mediated signal transduction
11/26/1998WO1998052947A1 Process for preparing 6-o-monoesters of castanospermine
11/26/1998WO1998052946A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
11/26/1998WO1998052943A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998WO1998052942A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052939A1 Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052935A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/26/1998WO1998052934A1 METHOD FOR THE SYNTHESIS OF 8-C-β-D-[2'-O-(E)-CINNAMOYL] GLYCOPYRANOSYL-2-[2-HYDROXY] PROPYL-7-METHOXY-5-METHYLCHROMONE
11/26/1998WO1998052933A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998WO1998052929A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
11/26/1998WO1998052927A1 Composition for treating skin conditions
11/26/1998WO1998052925A1 Analogs of duocarmycin and cc-1065
11/26/1998WO1998052915A2 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998WO1998052914A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998WO1998052910A1 Metalloproteinase inhibitors
11/26/1998WO1998052906A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998WO1998052899A1 Polyhydroxybenzene derivatives and preventive/remedy for bone and cartilage diseases
11/26/1998WO1998052898A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998WO1998052894A1 Cyclohexanediol derivatives
11/26/1998WO1998052614A2 Composition and method for enhancing transport across biological membranes
11/26/1998WO1998052612A1 Antiseptic composition
11/26/1998WO1998052611A1 Medicinal composition for prevention or treatment of hepatopathy
11/26/1998WO1998052607A1 88kda tumorigenic growth factor and antagonists
11/26/1998WO1998052606A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998WO1998052593A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998WO1998052591A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998WO1998052585A1 Immunomodulating, bile-derivable compositions for the treatment of viral disorders
11/26/1998WO1998052580A1 Treating asthma by preventing and/or accommodating for s-nitrosothiol breakdown
11/26/1998WO1998052579A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998WO1998052578A1 Fructan containing composition for the prevention and treatment of colon cancer
1 ... 6574 6575 6576 6577 6578 6579 6580 6581 6582 6583 6584 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 ... 7860